SHOULDER INNOVATIONS, INC.

SI
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001699350

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 14, 20268:23 PM ETSep 14, 2026Ball Robert JosephCEO & Executive ChairmanSSaleCommon Stock−10.18K$18.4478−$187.71K380.82K−2.6%SEC
Aug 28, 20264:11 PM ETAug 26, 2026Gilde Healthcare Holding B.V.10% OwnerSSaleCommon Stock−1.2K$22.60−$27.03K2.19M−0.1%SEC
Aug 24, 20267:36 PM ETAug 20 – Aug 24, 2026Gilde Healthcare Holding B.V.10% OwnerSSaleCommon Stock−25.1K$22.6087−$567.41K2.19M−1.1%SEC
Aug 18, 20264:47 PM ETAug 17 – Aug 18, 2026Ahearn Matthew FraserChief Operating OfficerSSaleCommon Stock−22.5K$20.658−$464.81K244.18K−8.4%SEC10b5-1
Aug 7, 20264:12 PM ETAug 5 – Aug 6, 2026Gilde Healthcare Holding B.V.10% OwnerSSaleCommon Stock−9.43K$22.6311−$213.48K2.21M−0.4%SEC
Aug 5, 20264:31 PM ETAug 3 – Aug 4, 2026Gilde Healthcare Holding B.V.10% OwnerSSaleCommon Stock−110.56K$22.7642−$2.52M2.22M−4.7%SEC
Aug 3, 20265:17 PM ETJul 30 – Jul 31, 2026Gilde Healthcare Holding B.V.10% OwnerSSaleCommon Stock−48.28K$23.0986−$1.12M2.33M−2.0%SEC
Jun 16, 2026Jun 12 – Jun 15, 2026Ahearn Matthew FraserChief Operating OfficerSSaleCommon Stock−20K$18.713−$374.26K269.18K−6.9%SEC10b5-1
Mar 17, 2026Mar 13, 2026Ball Robert JosephCEO & Executive ChairmanPPurchaseCommon Stock+2.2K$15.18+$33.4K278.87K+0.8%SEC
Mar 17, 2026Mar 13, 2026Buchholz RichardDirectorPPurchaseCommon Stock+1K$14.84+$14.84K13.67K+7.9%SEC
Mar 17, 2026Mar 13, 2026Points Jeffrey S.Chief Financial OfficerPPurchaseCommon Stock+2K$15.00+$30K70.79K+2.9%SEC
Dec 15, 2025Dec 11 – Dec 12, 2025Points Jeffrey S.Chief Financial OfficerPPurchaseCommon Stock+2K$14.8158+$29.63K54.45K+3.8%SEC
Dec 15, 2025Dec 11 – Dec 12, 2025Ball Robert JosephCEO & Executive ChairmanPPurchaseCommon Stock+7.2K$14.8625+$107.01K118.46K+6.5%SEC
Sep 15, 2025Sep 12, 2025Points Jeffrey S.CHIEF FINANCIAL OFFICERPPurchaseCommon Stock+1.6K$15.67+$25.07K52.45K+3.1%SEC
Sep 15, 2025Sep 11 – Sep 12, 2025Ball Robert JosephCEO & EXECUTIVE CHAIRMANPPurchaseCommon Stock+8K$15.3425+$122.74K111.26K+7.7%SEC
Aug 5, 20254:05 PM ETAug 1, 2025George Jean and 4 othersOther: Former 10% OwnerPPurchaseCommon Stock+266.67K$15.00+$4M1.89M+16.5%SEC
Aug 5, 2025Aug 1, 2025Tansey Casey MDirector, 10% OwnerPPurchaseCommon Stock+40K$15.00+$600K47.67K+521.8%SEC
Aug 5, 2025Aug 1, 2025Points Jeffrey S.CHIEF FINANCIAL OFFICERPPurchaseCommon Stock+50$15.00+$75050New positionSEC
Aug 5, 2025Aug 1, 2025Pardo Geoffrey BDirector, 10% OwnerPPurchaseCommon Stock+100K$15.00+$1.5M2.38M+4.4%SEC
Aug 5, 2025Aug 1, 2025Carusi Michael ADirectorPPurchaseCommon Stock+266.67K$15.00+$4M1.89M+16.5%SEC
Aug 5, 2025Aug 1, 2025Buchholz RichardDirectorPPurchaseCommon Stock+5K$15.00+$75K12.67K+65.2%SEC
Aug 5, 2025Aug 1, 2025Gilde Healthcare Holding B.V.10% OwnerPPurchaseCommon Stock+100K$15.00+$1.5M2.38M+4.4%SEC